Similar articles for PMID: 33097632

Year	Number of Results
1999	1
2016	2
2017	1
2018	9
2019	12
2020	31
2021	90
2022	153
2023	71
2024	0

1

Impact of ⁶⁸Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.

Röhrich M, Naumann P, Giesel FL, Choyke PL, Staudinger F, Wefers A, Liew DP, Kratochwil C, Rathke H, Liermann J, Herfarth K, Jäger D, Debus J, Haberkorn U, Lang M, Koerber SA. Röhrich M, et al. J Nucl Med. 2021 Jun 1;62(6):779-786. doi: 10.2967/jnumed.120.253062. Epub 2020 Oct 23. J Nucl Med. 2021. PMID: 33097632 Free PMC article.

2

Prognostic value of preoperative [⁶⁸ Ga]Ga-FAPI-04 PET/CT in patients with resectable pancreatic ductal adenocarcinoma in correlation with immunohistological characteristics.

Ding J, Qiu J, Hao Z, Huang H, Liu Q, Liu W, Ren C, Hacker M, Zhang T, Wu W, Huo L, Li X. Ding J, et al. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1780-1791. doi: 10.1007/s00259-022-06100-4. Epub 2023 Jan 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 36695823

3

⁶⁸Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas - Imaging analysis and histological validation.

Röhrich M, Syed M, Liew DP, Giesel FL, Liermann J, Choyke PL, Wefers AK, Ritz T, Szymbara M, Schillings L, Heger U, Rathke H, Kratochwil C, Huber PE, von Deimling A, Debus J, Kauczor HU, Haberkorn U, Adeberg S. Röhrich M, et al. Radiother Oncol. 2021 Jul;160:192-201. doi: 10.1016/j.radonc.2021.04.016. Epub 2021 May 1. Radiother Oncol. 2021. PMID: 33940087 Free PMC article.

4

Positron emission tomography and computed tomography with [⁶⁸Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.

Pang Y, Zhao L, Shang Q, Meng T, Zhao L, Feng L, Wang S, Guo P, Wu X, Lin Q, Wu H, Huang W, Sun L, Chen H. Pang Y, et al. Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1322-1337. doi: 10.1007/s00259-021-05576-w. Epub 2021 Oct 15. Eur J Nucl Med Mol Imaging. 2022. PMID: 34651226

5

PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using ⁶⁸Ga-FAP-2286: Comparison with ¹⁸F-FDG and ⁶⁸Ga-FAPI-46 in a Single-Center, Prospective Study.

Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, Zhang J, Chen X, Sun L, Chen H. Pang Y, et al. J Nucl Med. 2023 Mar;64(3):386-394. doi: 10.2967/jnumed.122.264544. Epub 2022 Sep 2. J Nucl Med. 2023. PMID: 36215571 Free PMC article.

6

Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.

Kosmala A, Serfling SE, Schlötelburg W, Lindner T, Michalski K, Schirbel A, Higuchi T, Hartrampf PE, Buck AK, Weich A, Werner RA. Kosmala A, et al. Clin Nucl Med. 2023 Jan 1;48(1):35-42. doi: 10.1097/RLU.0000000000004480. Epub 2022 Nov 3. Clin Nucl Med. 2023. PMID: 36354691 Free PMC article.

7

The Role of ⁶⁸Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience.

Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, Rathke H, Winter E, Lindner T, Syed M, Bhatti IA, Herfarth K, Choyke PL, Jaeger D, Haberkorn U, Debus J, Giesel FL. Koerber SA, et al. J Nucl Med. 2020 Sep;61(9):1331-1336. doi: 10.2967/jnumed.119.237016. Epub 2020 Feb 14. J Nucl Med. 2020. PMID: 32060216 Free PMC article.

8

Clinical utility of [⁶⁸Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma.

Zhao L, Pang Y, Zheng H, Han C, Gu J, Sun L, Wu H, Wu S, Lin Q, Chen H. Zhao L, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3606-3617. doi: 10.1007/s00259-021-05336-w. Epub 2021 Apr 1. Eur J Nucl Med Mol Imaging. 2021. PMID: 33792760

9

Head-to-Head Comparison of [⁶⁸ Ga]Ga-FAPI-46-PET/CT and [¹⁸F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer.

Wegen S, van Heek L, Linde P, Claus K, Akuamoa-Boateng D, Baues C, Sharma SJ, Schomäcker K, Fischer T, Roth KS, Klußmann JP, Marnitz S, Drzezga A, Kobe C. Wegen S, et al. Mol Imaging Biol. 2022 Dec;24(6):986-994. doi: 10.1007/s11307-022-01749-7. Epub 2022 Jun 30. Mol Imaging Biol. 2022. PMID: 35771317 Free PMC article. Clinical Trial.

10

⁶⁸Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, Debus J, Jäger D, Flechsig P, Altmann A, Mier W, Haberkorn U. Giesel FL, et al. J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2. J Nucl Med. 2019. PMID: 30072500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

292 results

Results by year